Steinbjørn Hansen

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

Johann S. de Bono, Stéphane Oudard, Mustafa Özgüroğlu et al. · The Lancet · 2010 · 3.3K citations

Medicine, Oncology, Pharmacology +16

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

Eugene D. Kwon, Charles G. Drake, H. I. Scher et al. · The Lancet Oncology · 2014 · 1.5K citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial—FIRSTANA

Stéphane Oudard, Karim Fizazi, Lisa Sengeløv et al. · Journal of Clinical Oncology · 2017 · 356 citations

Medicine, Pharmacology, Pharmacotherapy +17

Tumour‐associated microglia/macrophages predict poor prognosis in high‐grade gliomas and correlate with an aggressive tumour subtype

Mia Dahl Sørensen, Rikke Hedegaard Dahlrot, Henning B. Boldt et al. · Neuropathology and Applied Neurobiology · 2017 · 304 citations · Full text

Medicine, Oncology, Pathology +17

Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I–IV in the the Danish Neuro-Oncology Registry

Birthe Krogh Rasmussen, Steinbjørn Hansen, René Johannes Laursen et al. · Journal of Neuro-Oncology · 2017 · 293 citations

Medicine, Neurology, Oncology +12